453
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants

, , , , , & show all

References

  • Adams K, Beal MW. 2009. Implanon: a review of the literature with recommendations for clinical management. Journal of Midwifery & Women's Health 54:142–149.
  • American College of Obstetricians and Gynecologists (ACOG). 2012. Adolescents and long-acting reversible contraception: implants and intrauterine devices. Committee Opinion number 539. Obstetrics & Gynecology 120:983–988.
  • Arribas Mir L, Rueda Lozano D, Agrela Cardona M, Cedeño Benavides T, Olvera Porcel C, Bueno Cavanillas A. 2009. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain. Contraception 80:457–462.
  • Bateson D, McNamee K, Briggs P. 2013. Newer non-oral hormonal contraception. BMJ (Clinical Research Ed) 346:f341.
  • Belsey EM, Machin D, d’Arcangues C. 1986. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization special programme of research, development and research training in human reproduction. Contraception 34:253–260.
  • Blumenthal PD, Gemzell-Danielsson K, Marintcheva-Petrova M. 2008. Tolerability and clinical safety of implanon. European Journal of Contraception & Reproductive Health Care 13(Suppl. 1):29–36.
  • Brache V, Faundes A, Alvarez F. 2003. Risk–benefit effects of implantable contraceptives in women. Expert Opinion on Drug Safety 2:321–332.
  • Daphne Group. 2011. Hábitos Anticonceptivos de la mujer española. VII Encuesta Bayer Schering Pharma. Contraception in Spain 2011.
  • Darney P, Patel A, Rosen K, Shapiro L, Kaunitz A. 2009. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertility and Sterility 91:1646–1653.
  • Espey E, Ogburn T. 2011. Long-Acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstetrics and Gynecology 117:705–719.
  • Fischer MA. 2008. Implanon: a new contraceptive implant. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN 37:361–368.
  • Frost JJ, Darroch JE. 2008. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspectives on Sexual and Reproductive Health 40:94–104.
  • Gillies R, Scougall P, Nicklin S. 2011. Etonogestrel implants – case studies of median nerve injury following removal. Australian Family Physician 40:799–800.
  • Graesslin O, Korver T. 2008. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. European Journal of Contraception & Reproductive Health Care 13:4–12.
  • Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. 2008. The effects of implanon on menstrual bleeding patterns. European Journal of Contraception & Reproductive Health Care 13:13–28.
  • Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt H-J, Gemzell-Danielsson K. 2010. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 82:243–249.
  • Meirik O, Brache V, Orawan K, Habib NA, Schmidt J, Ortayli N, et al. 2013. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data. Contraception 87:113–120.
  • Palomba S, Falbo A, Di Cello A, Materazzo C, Zullo F. 2012. Nexplanon: the new implant for long-term contraception. A comprehensive descriptive review. Gynecological Endocrinology 28:710–721.
  • Randel A. 2012. Guidelines for the use of long-acting reversible contraceptives. American Family Physician 85:403–404.
  • Riney S, O’Shea B, Forde A. 2009. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting. Irish Medical Journal 102:24–25.
  • Shokeir T, Amr M, Abdelshaheed M. 2009. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Archives of Gynecology and Obstetrics 280:437–443.
  • World Health Organisation (WHO). 2010. Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone. 4th ed. Geneva: WHO Guidelines Approved by the Guidelines Review Committee.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.